REGULATED PRESS RELEASE published on 02/13/2025 at 07:01, 1 month 19 days ago bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes bioMérieux launches GENE-UP® TYPER, an innovative real-time PCR solution for rapid root cause analysis in food industries, targeting Listeria monocytogenes contamination BioMérieux Listeria Monocytogenes GENE-UP® TYPER Real-time PCR Root Cause Analysis
REGULATED PRESS RELEASE published on 02/13/2025 at 07:01, 1 month 19 days ago bioMérieux lance GENE-UP® TYPER, une solution diagnostique innovante destinée aux industries agroalimentaires pour analyser rapidement l’origine des contaminations par Listeria monocytogenes bioMérieux lance GENE-UP® TYPER, solution diagnostique PCR innovante pour identifier rapidement l’origine des contaminations par Listeria monocytogenes dans l'industrie agroalimentaire BioMérieux Listeria Monocytogenes Diagnostic PCR GENE-UP® TYPER Contamination
BRIEF published on 02/11/2025 at 07:06, 1 month 21 days ago BioMérieux Secures FDA Clearance for Enhanced Gastroenteritis Test BioMérieux FDA Clearance Healthcare Innovation Molecular Diagnostics Gastroenteritis
BRIEF published on 02/11/2025 at 07:06, 1 month 21 days ago BioMérieux : Feu vert de la FDA pour son test de gastroentérite FDA BioMérieux Diagnostic Rapide Gastroentérite BIOFIRE FILMARRAY
REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 1 month 21 days ago bioMérieux obtient l’autorisation de la FDA américaine pour la nouvelle version de son test moléculaire ciblant les causes de la gastroentérite, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux reçoit l'autorisation de la FDA américaine pour son test moléculaire BIOFIRE® FILMARRAY® Gastrointestinal Panel Mid ciblant la gastroentérite FDA BioMérieux BIOFIRE® Gastroentérite Test Moléculaire
REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 1 month 21 days ago bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux receives U.S. FDA clearance for the new version of its molecular test, the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, targeting causes of gastroenteritis. The test detects 11 common bacteria, viruses, and parasites from one sample in about 1 hour, improving patient outcomes BioMérieux FDA Clearance Gastroenteritis BIOFIRE® FILMARRAY® Molecular Test
BRIEF published on 02/06/2025 at 11:25, 1 month 26 days ago Biomérieux : Déclaration mensuelle sur les droits de vote et actions Droits De Vote Capital Social BioMérieux Actions 2025
BRIEF published on 02/06/2025 at 11:25, 1 month 26 days ago Biomérieux: Monthly statement on voting rights and shares Share Capital Voting Rights BioMérieux Actions 2025
REGULATED PRESS RELEASE published on 02/06/2025 at 11:20, 1 month 26 days ago Janvier 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux publie les informations mensuelles relatives au nombre total de droits de vote et d'actions conformément à la réglementation financière Droits De Vote Réglementation Financière BioMérieux Actions Informations Mensuelles
BRIEF published on 01/13/2025 at 07:20, 2 months 22 days ago BioMérieux à la 43ème J.P. Morgan HealthCare Conference BioMérieux Biologie Moléculaire J.P. Morgan Conference GO•28 Plan Acquisition Spinchip
Published on 04/04/2025 at 17:30, 1 hour 47 minutes ago Polaris Renewable Energy Announces Q1 2025 Investor Call Details
Published on 04/04/2025 at 15:10, 4 hours 7 minutes ago China Launches New Precision Strike Against Pengaton Rare Earth Supply Chains
Published on 04/04/2025 at 00:00, 19 hours 17 minutes ago Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Published on 04/03/2025 at 15:05, 1 day 4 hours ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 1 day 4 hours ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/04/2025 at 19:00, 17 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/04/2025 at 18:51, 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/04/2025 at 18:30, 47 minutes ago Forbo shareholders approved all proposals of the Board of Directors
Published on 04/04/2025 at 18:11, 1 hour 5 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/04/2025 at 18:00, 1 hour 17 minutes ago Sartorius to acquire microtissue business MatTek from Swedish BICO AB
Published on 04/04/2025 at 18:17, 59 minutes ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:17, 59 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 31 mars et le 3 avril 2025
Published on 04/04/2025 at 18:13, 1 hour 4 minutes ago Total number of voting rights and shares making up the share capital at March 31, 2025
Published on 04/04/2025 at 17:45, 1 hour 32 minutes ago LANSON-BCC : DOCUMENT D'ENREGISTREMENT UNIVERSEL 2024